Citation Impact
Citing Papers
An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice
2012
The gut microbiota and host health: a new clinical frontier
2015 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats
2015 Standout
Microbiota in health and diseases
2022 Standout
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
2013 Standout
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
2010 Standout
DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH
2011
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
The gut microbiota and obesity: from correlation to causality
2013
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Nonalcoholic fatty liver disease
2015
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders
2010
Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease? – A mechanistic hypothesis
2015
Burden of liver diseases in the world
2018 Standout
Prevalence and Predictive Factors of Non-Alcoholic Steatohepatitis (NASH) in Morbidly Obese Patients Undergoing Bariatric Surgery
2006
The role of the gut microbiota in nonalcoholic fatty liver disease
2010
Effects of bariatric surgery on nonalcoholic fatty liver disease: Preliminary findings after 2 years
2007
Optical Microscopy of Growing Insulin Amyloid Spherulites on Surfaces In Vitro
2005
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
2017 Standout
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
2018 Standout
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
2010 Standout
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*
2013 Standout
Toll-Like Receptor 4 Is Involved in the Development of Fructose-Induced Hepatic Steatosis in Mice†
2009
Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model
2014
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
2009 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Liver Damage in Obese Patients
2002
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
2020
Therapeutic Potential of Fecal Microbiota Transplantation
2013
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Triglyceride Levels and Not Adipokine Concentrations Are Closely Related to Severity of Nonalcoholic Fatty Liver Disease in an Obesity Surgery Cohort
2009
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Pseudoglandular (Adenoid, Acantholytic) Penile Squamous Cell Carcinoma
2009
Non-alcoholic fatty liver disease
2021 Standout
Lack of Exercise Is a Major Cause of Chronic Diseases
2012 Standout
The role of the gut microbiota in NAFLD
2016
The Effect of a Low-Carbohydrate, Ketogenic Diet on Nonalcoholic Fatty Liver Disease: A Pilot Study
2007
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
Histological Behavior of Hepatic Steatosis in Morbidly Obese Patients after Weight Loss Induced by Bariatric Surgery
2005
Role of the gut microbiota in nutrition and health
2018 Standout
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Intestinal microbiota in patients with nonalcoholic fatty liver disease
2013
Current understanding of the human microbiome
2018 Standout
Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASH
2012
Hepatic histology in obese patients undergoing bariatric surgery
2006
Influence of diet on the gut microbiome and implications for human health
2017 Standout
Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients
2001
Stress Induces Endotoxemia and Low-Grade Inflammation by Increasing Barrier Permeability
2015
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Molecular mechanism of Thioflavin-T binding to amyloid fibrils
2010 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
Short-chain fatty acids in control of body weight and insulin sensitivity
2015 Standout
Proteobacteria: microbial signature of dysbiosis in gut microbiota
2015 Standout
Moderate and severe traumatic brain injury in adults
2008 Standout
Nonalcoholic fatty liver disease
2005 Standout
The Role of Ultrasound in the Diagnosis of Hepatic Steatosis in Morbidly Obese Patients
2004
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Epidemiology and Natural History of NAFLD and NASH
2007
Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery
2015
The binding of thioflavin-T to amyloid fibrils: localisation and implications
2004
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Roux‐en‐Y Gastric Bypass Improves Liver Histology in Patients with Non‐Alcoholic Fatty Liver Disease
2005
Gut microbiota in human metabolic health and disease
2020 Standout
The human microbiome: at the interface of health and disease
2012 Standout
Multivariable Prognostic Analysis in Traumatic Brain Injury: Results from The IMPACT Study
2007
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome
2013
Protein Misfolding, Functional Amyloid, and Human Disease
2006 Standout
Supramolecular Polymerization
2009 Standout
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
2010
Microbial Translocation in Chronic Liver Diseases
2012
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
2016
Steatosis and Steatohepatitis: Complex Disorders
2014
The formation of spherulites by amyloid fibrils of bovine insulin
2004
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Fiber and Prebiotics: Mechanisms and Health Benefits
2013 Standout
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Hepatitis C and liver transplantation
2001
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition
2016 Standout
Microbial Translocation Across the GI Tract
2012
Gut Microbiota and Host Reaction in Liver Diseases
2015
Interactions Between Gut Microbiota and Host Metabolism Predisposing to Obesity and Diabetes
2010
Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity
2014
Hepatic toll‐like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD
2014
Works of Marta Mayorga being referenced
Adenoid squamous cell carcinoma of the larynx: an uncommon histological variant of squamous cell carcinoma
2006
Lipopolysaccharide-Binding Protein Plasma Levels and Liver TNF-Alpha Gene Expression in Obese Patients: Evidence for the Potential Role of Endotoxin in the Pathogenesis of Non-Alcoholic Steatohepatitis
2007
Involvement of the fas system in hepatitis C virus recurrence after liver transplantation
2000
Are there Predictive Factors of Severe Liver Fibrosis in Morbidly Obese Patients with Non-alcoholic Steatohepatitis?
2001
Primary amyloid tumor (amyloidoma) of the jejunum with spheroid type of amyloid
1999
Cerebral Apoptosis in Severe Traumatic Brain Injury Patients: An In Vitro, In Vivo , and Postmortem Study
2008